Login to Your Account

UK's Magnus launches with $25M round, 'real understanding of disease'

By Nuala Moran
Staff Writer

Tuesday, October 7, 2014
One of the academic lynchpins of UK biotech, John Martin, has attracted £15.5 million (US$24.9 million) in private equity for Magnus Life Sciences Ltd., a start-up shaped to overcome his frustrations at current shortcomings and gaps in the process of translating research from lab to bedside.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription